Cargando…
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer
BACKGROUND: Ovarian cancer, a highly aggressive and heterogeneous gynecological malignancy that has long been difficult for physicians to identify and treat, requires more effective and precise molecular targets. R-spondin 3 (RSPO3) is a secreted protein that plays a tumorigenic role in several huma...
Autores principales: | Gu, Haifeng, Tu, Hua, Liu, Lili, Liu, Ting, Liu, Zhimin, Zhang, Wei, Liu, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723610/ https://www.ncbi.nlm.nih.gov/pubmed/33313096 http://dx.doi.org/10.21037/atm-20-3731 |
Ejemplares similares
-
Astaxanthin prevents osteoarthritis by blocking Rspo2-mediated Wnt/β-catenin signaling in chondrocytes and abolishing Rspo2-related inflammatory factors in macrophages
por: Zhu, Chunhui, et al.
Publicado: (2023) -
Clear Cell Adenocarcinoma of Uterine Cervix: A Single Institution Retrospective Experience
por: Liu, Zhimin, et al.
Publicado: (2020) -
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
por: Mesci, Aruz, et al.
Publicado: (2019) -
Tracing the Origin of the RSPO2 Long-Hair Allele and Epistatic Interaction between FGF5 and RSPO2 in Sapsaree Dog
por: Kang, Mingue, et al.
Publicado: (2022) -
Is Routine Gastroscopy/Colonoscopy Reasonable in Patients With Suspected Ovarian Cancer: A Retrospective Study
por: Liu, Guochen, et al.
Publicado: (2021)